Mortality of HIV-1-infected patients in the first year of antiretroviral therapy: comparison between low-income and high-income countries

P Braitstein; MWG Brinkhof; F Dabis; M Schechter; A Boulle; P Miotti; R Wood; C Laurent; E Sprinz; C Seyler; D Bangsberg; E Balestre; JAC Sterne; MT May; M Egger

doi:10.1016/S0140-6736(06)68337-2

Mortality of HIV-1-infected patients in the first year of antiretroviral therapy: comparison between low-income and high-income countries

P Braitstein
, MWG Brinkhof
, F Dabis
, M Schechter
, A Boulle
, P Miotti
, R Wood
, C Laurent
, E Sprinz
, C Seyler
, D Bangsberg
, E Balestre
, JAC Sterne
, MT May
, M Egger

Bristol Medical School (PHS)

Research output: Contribution to journal › Article (Academic Journal) › peer-review

984 Citations (Scopus)

Translated title of the contribution	Mortality of HIV-1-infected patients in the first year of antiretroviral therapy: comparison between low-income and high-income countries
Original language	English
Pages (from-to)	817 - 824
Number of pages	8
Journal	Lancet
Volume	367 (9513)
DOIs	https://doi.org/10.1016/S0140-6736(06)68337-2
Publication status	Published - Mar 2006

Bibliographical note

Publisher: Elsevier
Other identifier: 01403736

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Access to Document

10.1016/S0140-6736(06)68337-2

http://tinyurl.com/38eyep

Handle.net

Persistent link

THE IMPACT OF HIGHLY EFFECTIVE ANTIRETROVIRAL THERAPY: MONITORING AND MODELLING BENEFIT AND HARM
Sterne, J. A. C. (Principal Investigator)
1/02/02 → 1/02/08
Project: Research

Cite this

Braitstein, P., Brinkhof, MWG., Dabis, F., Schechter, M., Boulle, A., Miotti, P., Wood, R., Laurent, C., Sprinz, E., Seyler, C., Bangsberg, D., Balestre, E., Sterne, JAC., May, MT., & Egger, M. (2006). Mortality of HIV-1-infected patients in the first year of antiretroviral therapy: comparison between low-income and high-income countries. Lancet, 367 (9513), 817 - 824. https://doi.org/10.1016/S0140-6736(06)68337-2

@article{d468f496c3094050b464d7318d7952c4,

title = "Mortality of HIV-1-infected patients in the first year of antiretroviral therapy: comparison between low-income and high-income countries",

author = "P Braitstein and MWG Brinkhof and F Dabis and M Schechter and A Boulle and P Miotti and R Wood and C Laurent and E Sprinz and C Seyler and D Bangsberg and E Balestre and JAC Sterne and MT May and M Egger",

note = "Publisher: Elsevier Other identifier: 01403736",

year = "2006",

month = mar,

doi = "10.1016/S0140-6736(06)68337-2",

language = "English",

volume = "367 (9513)",

pages = "817 -- 824",

journal = "Lancet",

issn = "1474-547X",

publisher = "Elsevier B.V.",

}

Braitstein, P, Brinkhof, MWG, Dabis, F, Schechter, M, Boulle, A, Miotti, P, Wood, R, Laurent, C, Sprinz, E, Seyler, C, Bangsberg, D, Balestre, E, Sterne, JAC, May, MT & Egger, M 2006, 'Mortality of HIV-1-infected patients in the first year of antiretroviral therapy: comparison between low-income and high-income countries', Lancet, vol. 367 (9513), pp. 817 - 824. https://doi.org/10.1016/S0140-6736(06)68337-2

TY - JOUR

T1 - Mortality of HIV-1-infected patients in the first year of antiretroviral therapy: comparison between low-income and high-income countries

AU - Braitstein, P

AU - Brinkhof, MWG

AU - Dabis, F

AU - Schechter, M

AU - Boulle, A

AU - Miotti, P

AU - Wood, R

AU - Laurent, C

AU - Sprinz, E

AU - Seyler, C

AU - Bangsberg, D

AU - Balestre, E

AU - Sterne, JAC

AU - May, MT

AU - Egger, M

N1 - Publisher: Elsevier Other identifier: 01403736

PY - 2006/3

Y1 - 2006/3

U2 - 10.1016/S0140-6736(06)68337-2

DO - 10.1016/S0140-6736(06)68337-2

M3 - Article (Academic Journal)

SN - 1474-547X

VL - 367 (9513)

SP - 817

EP - 824

JO - Lancet

JF - Lancet

ER -

Mortality of HIV-1-infected patients in the first year of antiretroviral therapy: comparison between low-income and high-income countries

Bibliographical note

UN SDGs

Access to Document

Handle.net

Projects

THE IMPACT OF HIGHLY EFFECTIVE ANTIRETROVIRAL THERAPY: MONITORING AND MODELLING BENEFIT AND HARM

Cite this